Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Platform-based
1.2.3 Instrument-based
1.3 Market by Application
1.3.1 Global Cancer Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Diagnostics Market Perspective (2019-2030)
2.2 Cancer Diagnostics Growth Trends by Region
2.2.1 Global Cancer Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cancer Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Cancer Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Cancer Diagnostics Market Dynamics
2.3.1 Cancer Diagnostics Industry Trends
2.3.2 Cancer Diagnostics Market Drivers
2.3.3 Cancer Diagnostics Market Challenges
2.3.4 Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Diagnostics Players by Revenue
3.1.1 Global Top Cancer Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Cancer Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Diagnostics Revenue
3.4 Global Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Diagnostics Revenue in 2023
3.5 Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Diagnostics Breakdown Data by Type
4.1 Global Cancer Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Cancer Diagnostics Forecasted Market Size by Type (2025-2030)
5 Cancer Diagnostics Breakdown Data by Application
5.1 Global Cancer Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Cancer Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cancer Diagnostics Market Size (2019-2030)
6.2 North America Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cancer Diagnostics Market Size by Country (2019-2024)
6.4 North America Cancer Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Diagnostics Market Size (2019-2030)
7.2 Europe Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cancer Diagnostics Market Size by Country (2019-2024)
7.4 Europe Cancer Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Cancer Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cancer Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Cancer Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Diagnostics Market Size (2019-2030)
9.2 Latin America Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cancer Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Cancer Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cancer Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Cancer Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Becton, Dickinson and Company
11.1.1 Becton, Dickinson and Company Company Detail
11.1.2 Becton, Dickinson and Company Business Overview
11.1.3 Becton, Dickinson and Company Cancer Diagnostics Introduction
11.1.4 Becton, Dickinson and Company Revenue in Cancer Diagnostics Business (2019-2024)
11.1.5 Becton, Dickinson and Company Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Detail
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Cancer Diagnostics Introduction
11.2.4 GE Healthcare Revenue in Cancer Diagnostics Business (2019-2024)
11.2.5 GE Healthcare Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Cancer Diagnostics Introduction
11.3.4 Abbott Revenue in Cancer Diagnostics Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Cancer Diagnostics Introduction
11.4.4 Roche Revenue in Cancer Diagnostics Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Cancer Diagnostics Introduction
11.5.4 Thermo Fisher Scientific Revenue in Cancer Diagnostics Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Detail
11.6.2 Agilent Technologies Business Overview
11.6.3 Agilent Technologies Cancer Diagnostics Introduction
11.6.4 Agilent Technologies Revenue in Cancer Diagnostics Business (2019-2024)
11.6.5 Agilent Technologies Recent Development
11.7 Illumina
11.7.1 Illumina Company Detail
11.7.2 Illumina Business Overview
11.7.3 Illumina Cancer Diagnostics Introduction
11.7.4 Illumina Revenue in Cancer Diagnostics Business (2019-2024)
11.7.5 Illumina Recent Development
11.8 Siemens Healthcare
11.8.1 Siemens Healthcare Company Detail
11.8.2 Siemens Healthcare Business Overview
11.8.3 Siemens Healthcare Cancer Diagnostics Introduction
11.8.4 Siemens Healthcare Revenue in Cancer Diagnostics Business (2019-2024)
11.8.5 Siemens Healthcare Recent Development
11.9 C.R. Bard
11.9.1 C.R. Bard Company Detail
11.9.2 C.R. Bard Business Overview
11.9.3 C.R. Bard Cancer Diagnostics Introduction
11.9.4 C.R. Bard Revenue in Cancer Diagnostics Business (2019-2024)
11.9.5 C.R. Bard Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details